Search
for
Sort by
Research 121–150 of 1000+
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- The role of janus kinases in the treatment of autoimmune skin diseases
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- JAK Inhibitors for Treatment of Alopecia Areata